Lyra Therapeutics, Inc.LYRANASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank96
Year-over-Year Change
Year-over-year operating income growth rate
Latest
25.75%
↑ 468% vs avg
Percentile
P96
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
-6.99%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 25.75% |
| Q2 2025 | 4.67% |
| Q1 2025 | 22.50% |
| Q4 2024 | 8.31% |
| Q3 2024 | 74.59% |
| Q2 2024 | -108.19% |
| Q1 2024 | -42.77% |
| Q4 2023 | 2.08% |
| Q3 2023 | -1.96% |
| Q2 2023 | 4.68% |
| Q1 2023 | -14.24% |
| Q4 2022 | -2.22% |
| Q3 2022 | -2.96% |
| Q2 2022 | -20.75% |
| Q1 2022 | 12.56% |
| Q4 2021 | -23.08% |
| Q3 2021 | -0.14% |
| Q2 2021 | -41.30% |
| Q1 2021 | -11.03% |
| Q4 2020 | -10.84% |
| Q3 2020 | -40.00% |
| Q2 2020 | -6.99% |
| Q1 2020 | 3.19% |
| Q4 2019 | -3.83% |
| Q3 2019 | 1.28% |
| Q2 2019 | -18.13% |
| Q1 2019 | 0.00% |